EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document E2007C1108(02)
Medicinal products — List of marketing authorisations granted by the EEA EFTA States for the first half of 2006
Medicinal products — List of marketing authorisations granted by the EEA EFTA States for the first half of 2006
Medicinal products — List of marketing authorisations granted by the EEA EFTA States for the first half of 2006
IO C 266, 8.11.2007, p. 7–17
(BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
8.11.2007 |
EN |
Official Journal of the European Union |
C 266/7 |
Medicinal products — List of marketing authorisations granted by the EEA EFTA States for the first half of 2006
(2007/C 266/05)
Subcommittee I — On the free movement of goods
With reference to EEA Joint Committee Decision No 74/1999 of 28 May 1999, the EEA Joint Committee is invited to note, at the meeting on 8 December 2006, the following lists concerning marketing authorisations for medicinal products for the period 1 January-30 June 2006:
|
ANNEX I |
List of new marketing authorisations |
|
ANNEX II |
List of renewed marketing authorisations |
|
ANNEX III |
List of extended marketing authorisations |
|
ANNEX IV |
List of withdrawn marketing authorisations |
|
ANNEX V |
List of suspended marketing authorisations |
ANNEX I
List of new marketing authorisations
The following marketing authorisations have been granted in the EEA EFTA States during the period 1 January-30 June 2006:
|
EU-Number |
Product |
Country |
Date of authorisation |
|
EU/1/01/183/020-029 |
HBVAXPRO |
Liechtenstein |
28.2.2006 |
|
EU/1/01/187/001 |
DepoCyte |
Liechtenstein |
31.1.2006 |
|
EU/1/03/258/015-022 |
Avandamet |
Liechtenstein |
28.2.2006 |
|
EU/1/03/262/001-006 |
Emend |
Liechtenstein |
31.1.2006 |
|
EU/1/03/265/003-004 |
Bonviva |
Liechtenstein |
31.1.2006 |
|
EU/1/03/266/001-002 |
Bondenza |
Liechtenstein |
28.2.2006 |
|
EU/1/04/307/005-010 |
Zonegran |
Liechtenstein |
31.1.2006 |
|
EU/1/05/322/001 |
Yttriga |
Liechtenstein |
31.1.2006 |
|
EU/1/05/322/001/IS |
Yttriga |
Iceland |
17.2.2006 |
|
EU/1/05/322/001/NO |
Yttriga |
Norway |
10.2.2006 |
|
EU/1/05/323/001/NO-011/NO |
ProQuad |
Norway |
24.4.2006 |
|
EU/1/05/323/001-011 |
ProQuad |
Liechtenstein |
30.4.2006 |
|
EU/1/05/323/001-011/IS |
ProQuad |
Iceland |
25.4.2006 |
|
EU/1/05/324/001 |
Naglazyme |
Liechtenstein |
31.1.2006 |
|
EU/1/05/324/001/IS |
Naglazyme |
Iceland |
22.6.2006 |
|
EU/1/05/324/01/NO |
Naglazyme |
Norway |
23.2.2006 |
|
EU/1/05/325/001 |
Macugen |
Liechtenstein |
28.2.2006 |
|
EU/1/05/325/001/IS |
Macugen |
Iceland |
10.3.2006 |
|
EU/1/05/325/001/NO |
Macugen |
Norway |
2.3.2006 |
|
EU/1/05/326/001 |
Ionsys |
Liechtenstein |
31.1.2006 |
|
EU/1/05/326/001/IS |
Ionsys |
Iceland |
22.2.2006 |
|
EU/1/05/326/001/NO |
Ionsys |
Norway |
16.2.2006 |
|
EU/1/05/327/001/NO-017/NO |
Exubera |
Norway |
16.2.2006 |
|
EU/1/05/327/001-017 |
Exubera |
Liechtenstein |
31.1.2006 |
|
EU/1/05/327/001-017/IS |
Exubera |
Iceland |
22.3.2006 |
|
EU/1/05/328/001/NO-002/NO |
Cubicin |
Norway |
16.2.2006 |
|
EU/1/05/328/001-002 |
Cubicin |
Liechtenstein |
28.2.2006 |
|
EU/1/05/328/001-002/IS |
Cubicin |
Iceland |
13.2.2006 |
|
EU/1/05/329/001/NO-005/NO |
Kiovig |
Norway |
27.1.2006 |
|
EU/1/05/329/001-005 |
Kiovig |
Liechtenstein |
31.1.2006 |
|
EU/1/05/329/001-005/IS |
Kiovig |
Iceland |
10.2.2006 |
|
EU/1/05/330/001/NO-004/NO |
Rotarix |
Norway |
8.3.2006 |
|
EU/1/05/330/001-004 |
Rotarix |
Liechtenstein |
28.2.2006 |
|
EU/1/05/330/001-004/IS |
Rotarix |
Iceland |
27.4.2006 |
|
EU/1/05/331/001/NO-013/NO |
Neupro |
Norway |
17.3.2006 |
|
EU/1/05/331/001-013 |
Neupro |
Liechtenstein |
28.2.2006 |
|
EU/1/05/331/001-013/IS |
Neupro |
Iceland |
10.4.2006 |
|
EU/1/06/332/001/NO-003/NO |
Omnitrope |
Norway |
5.5.2006 |
|
EU/1/06/332/001-003 |
Omnitrope |
Liechtenstein |
30.4.2006 |
|
EU/1/06/332/001-003/IS |
Omnitrope |
Iceland |
11.5.2006 |
|
EU/1/06/333/001/NO-003/NO |
Myozyme |
Norway |
8.5.2006 |
|
EU/1/06/333/001-003 |
Myozyme |
Liechtenstein |
30.4.2006 |
|
EU/1/06/334/001/NO-004/NO |
Evoltra |
Norway |
27.6.2006 |
|
EU/1/06/334/001-004/IS |
Evoltra |
Iceland |
26.6.2006 |
|
EU/1/06/335/001 |
Valtropin |
Liechtenstein |
30.6.2006 |
|
EU/1/06/335/001/IS |
Valtropin |
Iceland |
12.5.2006 |
|
EU/1/06/335/001/NO |
Valtropin |
Norway |
24.5.2006 |
|
EU/1/06/336/001 |
Tygacil |
Liechtenstein |
30.6.2006 |
|
EU/1/06/336/001/IS |
Tygacil |
Iceland |
1.6.2006 |
|
EU/1/06/336/001/NO |
Tygacil |
Norway |
24.5.2006 |
|
EU/1/06/337/001/NO-013/NO |
M-M-Rvaxpro |
Norway |
19.5.2006 |
|
EU/1/06/337/001-013 |
M-M-Rvaxpro |
Liechtenstein |
30.6.2006 |
|
EU/1/06/337/001-013/IS |
M-M-Rvaxpro |
Iceland |
13.6.2006 |
|
EU/1/06/338/001/NO-003/NO |
DuoTrav |
Norway |
10.5.2006 |
|
EU/1/06/338/001-003 |
DuoTrav |
Liechtenstein |
30.6.2006 |
|
EU/1/06/338/001-003/IS |
DuoTrav |
Iceland |
12.5.2006 |
|
EU/1/06/339/001/NO-002/NO |
Preotact |
Norway |
19.5.2006 |
|
EU/1/06/339/001-002 |
Preotact |
Liechtenstein |
30.6.2006 |
|
EU/1/06/339/001-002/IS |
Preotact |
Iceland |
18.5.2006 |
|
EU/1/06/340/001/NO-002/NO |
Ganfort |
Norway |
1.6.2006 |
|
EU/1/06/340/001-002 |
Ganfort |
Liechtenstein |
30.6.2006 |
|
EU/1/06/340/001-002/IS |
Ganfort |
Iceland |
15.6.2006 |
|
EU/1/06/341/001/NO-013/NO |
Zostavax |
Norway |
6.6.2006 |
|
EU/1/06/341/001-013 |
Zostavax |
Liechtenstein |
30.6.2006 |
|
EU/1/06/341/001-013/IS |
Zostavax |
Iceland |
19.6.2006 |
|
EU/1/06/344/001/NO-009/NO |
Acomplia |
Norway |
30.6.2006 |
|
EU/1/06/344/001-009 |
Acomplia |
Liechtenstein |
30.6.2006 |
|
EU/1/06/345/001/NO-009/NO |
Zimulti |
Norway |
30.6.2006 |
|
EU/1/06/345/001-009 |
Zimulti |
Liechtenstein |
30.6.2006 |
|
EU/1/96/022/019-022 |
Zyprexa |
Liechtenstein |
31.1.2006 |
|
EU/1/97/043/003 |
Revasc |
Liechtenstein |
31.1.2006 |
|
EU/1/97/044/007-008 |
Tasmar |
Liechtenstein |
28.2.2006 |
|
EU/1/97/046/031-033 |
Aprovel |
Liechtenstein |
31.1.2006 |
|
EU/1/97/049/031-033 |
Karvea |
Liechtenstein |
31.1.2006 |
|
EU/1/97/055/003 |
Viramune |
Liechtenstein |
31.1.2006 |
|
EU/1/98/063/007 |
Rebif |
Liechtenstein |
31.1.2006 |
|
EU/2/00/025/001-004 |
Advasure |
Liechtenstein |
28.2.2006 |
|
EU/2/03/037/005 |
ProteqFlu |
Liechtenstein |
28.2.2006 |
|
EU/2/03/038/005 |
ProteqFlu Te |
Liechtenstein |
28.2.2006 |
|
EU/2/04/043/001 |
Equilis StrepE |
Liechtenstein |
31.1.2006 |
|
EU/2/04/044/001 |
Aivlosin |
Liechtenstein |
31.1.2006 |
|
EU/2/04/044/002-005 |
Aivlosin |
Liechtenstein |
28.2.2006 |
|
EU/2/06/058/001/NO-003/NO |
Flexicam |
Norway |
3.5.2006 |
|
EU/2/06/058/001-003 |
Flexicam |
Liechtenstein |
30.4.2006 |
|
EU/2/06/058/001-003/IS |
Flexicam |
Iceland |
22.4.2006 |
|
EU/2/06/059/001 |
Convenia |
Liechtenstein |
30.6.2006 |
|
EU/2/97/004/014-015 |
Metacam |
Liechtenstein |
28.2.2006 |
ANNEX II
List of renewed marketing authorisations
The following marketing authorisations have been renewed in the EEA EFTA States during the period 1 January-30 June 2006:
|
EU-Number |
Product |
Country |
Date of renewal |
|
EU/1/00/154/001/NO-002/NO |
Neospect |
Norway |
27.2.2006 |
|
EU/1/00/154/001-002 |
NeoSpect |
Liechtenstein |
28.2.2006 |
|
EU/1/00/154/001-002/IS |
NeoSpect |
Iceland |
22.2.2006 |
|
EU/1/00/155/001/NO-006/NO |
Luveris |
Norway |
27.2.2006 |
|
EU/1/00/155/001-006 |
Luveris |
Liechtenstein |
31.1.2006 |
|
EU/1/00/155/001-006/IS |
Luveris |
Iceland |
25.4.2006 |
|
EU/1/00/156/002/NO-003/NO |
Trizivir |
Norway |
27.4.2006 |
|
EU/1/00/156/002-003 |
Trizivir |
Liechtenstein |
30.4.2006 |
|
EU/1/00/157/001-034 |
Azomyr |
Liechtenstein |
28.2.2006 |
|
EU/1/00/160/001-034 |
Aerius |
Liechtenstein |
28.2.2006 |
|
EU/1/00/161/001-034 |
Neoclarityn |
Liechtenstein |
28.2.2006 |
|
EU/1/00/163/001/NO |
Xeloda |
Norway |
3.3.2006 |
|
EU/1/00/163/001-002 |
Xeloda |
Liechtenstein |
28.2.2006 |
|
EU/1/00/163/001-002/IS |
Xeloda |
Iceland |
7.3.2006 |
|
EU/1/00/163/002/NO |
Xeloda |
Norway |
3.3.2006 |
|
EU/1/00/164/003/NO-006/NO |
NutropinAq |
Norway |
20.4.2006 |
|
EU/1/00/164/003-005 |
NutropinAq |
Liechtenstein |
30.4.2006 |
|
EU/1/00/164/003-005/IS |
NutropinAq |
Iceland |
18.5.2006 |
|
EU/1/00/165/001/NO-007/NO |
Ovitrelle |
Norway |
2.3.2006 |
|
EU/1/00/165/001-007 |
Ovitrelle |
Liechtenstein |
28.2.2006 |
|
EU/1/00/165/007/IS |
Ovitrelle |
Iceland |
11.4.2006 |
|
EU/1/00/166/001/NO-003/NO |
NeuroBloc |
Norway |
3.5.2006 |
|
EU/1/00/166/001-003 |
NeuroBloc |
Liechtenstein |
30.4.2006 |
|
EU/1/00/166/001-003/IS |
NeuroBloc |
Iceland |
9.6.2006 |
|
EU/1/00/167/001/NO-007/NO |
Prevenar |
Norway |
3.5.2006 |
|
EU/1/00/167/001-007 |
Prevenar |
Liechtenstein |
30.4.2006 |
|
EU/1/00/167/001-007/IS |
Prevenar |
Iceland |
30.5.2006 |
|
EU/1/00/169/002/NO-004/NO |
Metalyse |
Norway |
14.3.2006 |
|
EU/1/00/169/004-006 |
Metalyse |
Liechtenstein |
30.4.2006 |
|
EU/1/00/169/004-006/IS |
Metalyse |
Iceland |
11.4.2006 |
|
EU/1/00/170/001/NO-002/NO |
Fasturtec |
Norway |
27.2.2006 |
|
EU/1/00/170/001-002 |
Fasturtec |
Liechtenstein |
28.2.2006 |
|
EU/1/00/170/001-002(IS |
Fasturtec |
Iceland |
7.3.2006 |
|
EU/1/01/171/001,007-012/IS |
Rapamune |
Iceland |
8.6.2006 |
|
EU/1/01/171/001/NO, 007/NO-012/NO |
Rapamune |
Norway |
5.5.2006 |
|
EU/1/01/172/001/NO-003/NO |
Kaletra |
Norway |
26.4.2006 |
|
EU/1/01/172/001-003 |
Kaletra |
Liechtenstein |
30.4.2006 |
|
EU/1/01/172/001-003/IS |
Kaletra |
Iceland |
23.5.2006 |
|
EU/1/01/173/001/NO-003/NO |
Vaniqa |
Norway |
9.5.2006 |
|
EU/1/01/173/001-003 |
Vaniqa |
Liechtenstein |
30.4.2006 |
|
EU/1/01/173/001-003/IS |
Vaniqa |
Iceland |
7.6.2006 |
|
EU/1/01/174/001/NO-007/NO |
Starlix |
Norway |
23.5.2006 |
|
EU/1/01/174/001-021 |
Starlix |
Liechtenstein |
30.6.2006 |
|
EU/1/01/174/001-021/IS |
Starlix |
Iceland |
7.6.2006 |
|
EU/1/01/175/001, 004-007, 008, 011-014, 015, 018-021/IS |
Trazec |
Iceland |
7.6.2006 |
|
EU/1/01/175/001, 004-008, 011-015, 018-021 |
Trazec |
Liechtenstein |
30.6.2006 |
|
EU/1/01/175/001/NO, 004/NO-007/NO, 008/NO, 011/NO-014/NO, 015/NO, 018/NO-021/NO |
Trazec |
Norway |
23.5.2006 |
|
EU/1/01/176/001/NO-003/NO |
Zometa |
Norway |
2.5.2006 |
|
EU/1/01/176/001-006 |
Zometa |
Liechtenstein |
30.6.2006 |
|
EU/1/01/176/001-006/IS |
Zometa |
Iceland |
22.5.2006 |
|
EU/1/01/177/001/NO-002/NO |
SonoVue |
Norway |
4.5.2006 |
|
EU/1/01/177/001-002 |
SonoVue |
Liechtenstein |
30.4.2006 |
|
EU/1/01/177/002/IS |
SonoVue |
Iceland |
8.6.2006 |
|
EU/1/01/178/001/IS |
Targretin |
Iceland |
9.6.2006 |
|
EU/1/01/178/001/NO |
Targretin |
Norway |
16.5.2006 |
|
EU/1/01/179/001 |
Osigraft |
Liechtenstein |
30.6.2006 |
|
EU/1/01/179/001/NO |
Osigraft |
Norway |
30.5.2006 |
|
EU/1/01/184/001/NO-056/NO |
Nespo |
Norway |
26.6.2006 |
|
EU/1/01/184/001-056 |
Nespo |
Liechtenstein |
30.6.2006 |
|
EU/1/01/185/001/NO-056/NO |
Aranesp |
Norway |
26.6.2006 |
|
EU/1/01/185/001-056 |
Aranesp |
Liechtenstein |
30.6.2006 |
|
EU/1/01/187/001 |
DepoCyte |
Liechtenstein |
30.6.2006 |
|
EU/1/01/195/001/NO-015 /NO |
Liprolog |
Norway |
14.3.2006 |
|
EU/1/01/195/001-015 |
Liprolog |
Liechtenstein |
28.2.2006 |
|
EU/1/01/195/001-015/IS |
Liprolog |
Iceland |
13.3.2006 |
|
EU/1/03/262/007-008/IS |
Emend |
Iceland |
19.6.2006 |
|
EU/1/95/001/001, 003-005, 009, 012, 021-022, 025-028, 031-035 |
Gonal-f |
Liechtenstein |
31.1.2006 |
|
EU/1/95/002/001/NO-002/NO |
Taxotere |
Norway |
23.2.2006 |
|
EU/1/95/002/001-002 |
Taxotere |
Liechtenstein |
31.1.2006 |
|
EU/1/95/002/001-002/IS |
Taxotere |
Iceland |
23.2.2006 |
|
EU/1/95/003/003/NO-004/NO |
Betaferon |
Norway |
2.3.2006 |
|
EU/1/95/003/003-004 |
Betaferon |
Liechtenstein |
28.2.2006 |
|
EU/1/95/003/003-004/IS |
Betaferon |
Iceland |
10.4.2006 |
|
EU/1/96/004/001/NO-002/NO |
Fareston |
Norway |
1.3.2006 |
|
EU/1/96/004/001-002 |
Fareston |
Liechtenstein |
28.2.2006 |
|
EU/1/96/005/001/NO-006/NO |
CellCept |
Norway |
6.4.2006 |
|
EU/1/96/005/001-006 |
CellCept |
Liechtenstein |
30.4.2006 |
|
EU/1/96/005/001-006/IS |
CellCept |
Iceland |
5.5.2006 |
|
EU/1/96/006/001/NO-003/NO |
Novoseven |
Norway |
3.3.2006 |
|
EU/1/96/006/001-003 |
NovoSeven |
Liechtenstein |
28.2.2006 |
|
EU/1/96/006/001-003/IS |
NovoSeven |
Iceland |
10.4.2006 |
|
EU/1/96/007/002, 004-006, 008, 010-011, 015-021, 023-030 |
Humalog |
Liechtenstein |
30.4.2006 |
|
EU/1/96/007/002, 004-006, 008, 010-011, 015-021, 023-030/IS |
Humalog |
Iceland |
13.3.2006 |
|
EU/1/96/007/002/NO, 004/NO-006/NO, 008/NO, 010/NO-011/NO, 015/NO-021/NO, 023/NO-030/NO |
Humalog |
Norway |
3.3.2006 |
|
EU/1/96/008/001/NO-040/NO |
Puregon |
Norway |
26.6.2006 |
|
EU/1/96/008/001-041 |
Puregon |
Liechtenstein |
30.6.2006 |
|
EU/1/96/009/001/NO-002/NO |
Zerit |
Norway |
2.5.2006 |
|
EU/1/96/009/001-009 |
Zerit |
Liechtenstein |
30.4.2006 |
|
EU/1/96/009/001-009/IS |
Zerit |
Iceland |
24.5.2006 |
|
EU/1/96/011/001/NO-004/NO |
Caelyx |
Norway |
26.5.2006 |
|
EU/1/96/011/001-004 |
Caelyx |
Liechtenstein |
30.6.2006 |
|
EU/1/96/011/001-004/IS |
Caelyx |
Iceland |
16.6.2006 |
|
EU/1/98/093/002/IS |
Forcaltonin |
Iceland |
31.5.2006 |
|
EU/1/98/093/002/NO |
Forcaltonin |
Norway |
21.6.2006 |
|
EU/2/00/019/001-003/IS |
Purevax FeLV |
Iceland |
9.3.2006 |
|
EU/2/00/025/001/NO-004/NO |
Advasure |
Norway |
15.3.2006 |
|
EU/2/00/026/001/NO-004/NO |
Porcilis AR-T DF |
Norway |
10.3.2006 |
|
EU/2/00/026/001-004 |
Porcilis AR-T DF |
Liechtenstein |
28.2.2006 |
|
EU/2/00/026/001-004/IS |
Porcilis AR-T DF |
Iceland |
8.3.2006 |
|
EU/2/00/027/001/NO-003/NO |
Pirsue |
Norway |
10.3.2006 |
|
EU/2/00/027/001-003 |
Pirsue |
Liechtenstein |
28.2.2006 |
|
EU/2/00/028/002/NO-008 /NO |
Zubrin |
Norway |
7.4.2006 |
|
EU/2/00/028/002-008 |
Zubrin |
Liechtenstein |
30.4.2006 |
|
EU/2/00/028/002-008/IS |
Zubrin |
Iceland |
11.4.2006 |
|
EU/2/01/029/001/NO-003/NO |
Eurican Herpes |
Norway |
18.5.2006 |
|
EU/2/01/029/001-003 |
Eurican Herpes |
Liechtenstein |
30.4.2006 |
|
EU/2/01/029/001-003/IS |
Eurican Herpes |
Iceland |
8.6.2006 |
|
EU/2/96/001/001-010 |
Porcilis Porcoli |
Liechtenstein |
30.4.2006 |
|
EU/2/96/001/NO-010/NO |
Porcilis Porcoli |
Norway |
5.5.2006 |
ANNEX III
List of extended marketing authorisations
The following marketing authorisations have been extended in the EEA EFTA States during the period 1 January-30 June 2006:
|
EU-Number |
Product |
Country |
Date of extention |
|
EU/1/00/137/013-018 |
Avandia |
Liechtenstein |
30.6.2006 |
|
EU/1/00/146/030 |
Keppra |
Liechtenstein |
30.4.2006 |
|
EU/1/00/146/030/IS |
Keppra |
Iceland |
7.4.2006 |
|
EU/1/00/146/030/NO |
Keppra |
Norway |
28.4.2006 |
|
EU/1/00/150/016-024 |
Actos |
Liechtenstein |
30.4.2006 |
|
EU/1/00/151/014-022 |
Glustin |
Liechtenstein |
30.4.2006 |
|
EU/1/00/162/019-021 |
Prandin |
Liechtenstein |
30.6.2006 |
|
EU/1/03/255/004-005 |
Ventavis |
Liechtenstein |
30.6.2006 |
|
EU/1/03/262/007/NO-008/NO |
Emend |
Norway |
28.6.2006 |
|
EU/1/03/262/007-008 |
Emend |
Liechtenstein |
30.6.2006 |
|
EU/1/03/262/007-008/IS |
Emend |
Iceland |
19.6.2006 |
|
EU/1/03/265/005/NO-006/NO |
Bonviva |
Norway |
2.5.2006 |
|
EU/1/03/265/005-006/IS |
Bonviva |
Iceland |
12.6.2006 |
|
EU/1/03/266/005/NO-006/NO |
Bondenza |
Norway |
8.5.2006 |
|
EU/1/04/279/033/NO-035/NO |
Lyrica |
Norway |
19.6.2006 |
|
EU/1/04/279/033-035 |
Lyrica |
Liechtenstein |
30.6.2006 |
|
EU/1/04/296/007 |
Cymbalta |
Liechtenstein |
30.4.2006 |
|
EU/1/04/296/008 |
Cymbalta |
Liechtenstein |
30.6.2006 |
|
EU/1/04/297/007 |
Xeristar |
Liechtenstein |
30.4.2006 |
|
EU/1/04/297/008 |
Xeristar |
Liechtenstein |
30.6.2006 |
|
EU/1/04/302/004 |
Prialt |
Liechtenstein |
30.4.2006 |
|
EU/1/04/302/004/IS |
Prialt |
Iceland |
22.4.2006 |
|
EU/1/04/302/004/NO |
Prialt |
Norway |
29.3.2006 |
|
EU/1/05/319/003-004 |
Xolair |
Liechtenstein |
30.6.2006 |
|
EU/1/96/007/029-030 |
Humalog |
Liechtenstein |
30.4.2006 |
|
EU/1/98/063/007/IS |
Rebif |
Iceland |
30.5.2006 |
|
EU/1/98/063/007/NO |
Rebif |
Norway |
16.2.2006 |
|
EU/1/98/076/022-024 |
NovoNorm |
Liechtenstein |
30.6.2006 |
|
EU/1/98/089/017-019 |
Pritor |
Liechtenstein |
30.4.2006 |
|
EU/1/99/107/005 |
Rebetol |
Liechtenstein |
30.4.2006 |
|
EU/2/00/019/005-007/IS |
Purevax FeL V |
Iceland |
9.3.2006 |
|
EU/2/02/035/007 |
SevoFlo |
Liechtenstein |
30.4.2006 |
|
EU/2/03/037/005/NO |
Proteqflu |
Norway |
15.3.2006 |
|
EU/2/03/038/005/NO |
Proteqflu-Te |
Norway |
15.3.2006 |
|
EU/2/04/044/002/NO |
Aivlosin |
Norway |
4.3.2006 |
|
EU/2/04/044/003-005/IS |
Aivlosin |
Iceland |
22.3.2006 |
|
EU/2/97/004/016/NO-023/NO |
Metacam |
Norway |
22.4.2006 |
|
EU/2/97/004/016-023 |
Metacam |
Liechtenstein |
30.4.2006 |
|
EU/2/97/004/016-023/IS |
Metacam |
Iceland |
7.4.2006 |
ANNEX IV
List of withdrawn marketing authorisations
The following marketing authorisations have been withdrawn in the EEA EFTA States during the period 1 January-30 June 2006:
|
EU-Number |
Product |
Country |
Date of withdrawal |
|
EU/1/00/137/001 |
Avandia |
Liechtenstein |
30.6.2006 |
|
EU/1/01/183/002-003, 006, 009-010, 012, 014, 016-17 |
HBVAXPRO |
Liechtenstein |
28.2.2006 |
|
EU/1/02/245/001 |
Theryttrex |
Liechtenstein |
28.2.2006 |
|
EU/1/02/245/001/IS |
Theryttrex |
Iceland |
10.2.2006 |
|
EU/1/06/024/006, 009 |
Crixivan |
Liechstenstein |
31.1.2006 |
|
EU/1/96/022/001, 003, 005, 007, 013, 015 |
Zyprexa |
Liechstenstein |
31.1.2006 |
|
EU/1/97/052/001/NO-006/NO, 009/NO-010/NO |
Daquiran |
Norway |
22.2.2006 |
|
EU/1/97/052/001-006, 009-010 |
Daquiran |
Liechtenstein |
28.2.2006 |
|
EU/1/97/052/001-010/IS |
Daquiran |
Iceland |
10.2.2006 |
|
EU/1/98/075/001-002 |
Fortovase |
Liechtenstein |
30.6.2006 |
|
EU/1/98/075/001-002/IS |
Fortovase- Saquinavir |
Iceland |
26.6.2006 |
|
EU/1/98/087/001/NO-003/NO |
Infergen |
Norway |
30.5.2006 |
|
EU/1/98/087/001-003 |
Infergen |
Liechtenstein |
30.6.2006 |
|
EU/1/98/087/001-003/IS |
Infergen |
Iceland |
16.6.2006 |
|
EU/2/00/028/001 |
Zubrin |
Liechtenstein |
28.2.2006 |
|
EU/2/98/010/001-003, 015-016, 019-020 |
Econor |
Liechtenstein |
31.1.2006 |
ANNEX V
List of suspended marketing authorisations
The following marketing authorisations have been suspended in the EEA EFTA States during the period 1 January-30 June 2006:
|
EU-Number |
Product |
Country |
Date of suspention |
|
EU/1/02/239/001-030 |
Bextra |
Liechtenstein |
31.1.2006 |